Arrowhead Pharmaceuticals, Inc. (ARWR)
86.34
-0.15
(-0.17%)
USD |
NASDAQ |
Sep 04, 16:00
86.95
+0.61
(+0.71%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Market Cap : 12.19B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 12.19B |
| September 03, 2026 | 12.21B |
| September 02, 2026 | 12.05B |
| September 01, 2026 | 11.68B |
| August 31, 2026 | 11.63B |
| August 28, 2026 | 11.98B |
| August 27, 2026 | 12.50B |
| August 26, 2026 | 12.58B |
| August 25, 2026 | 12.54B |
| August 24, 2026 | 12.24B |
| August 21, 2026 | 12.29B |
| August 20, 2026 | 12.35B |
| August 19, 2026 | 12.62B |
| August 18, 2026 | 12.41B |
| August 17, 2026 | 12.52B |
| August 14, 2026 | 12.23B |
| August 13, 2026 | 12.08B |
| August 12, 2026 | 12.31B |
| August 11, 2026 | 12.59B |
| August 10, 2026 | 12.47B |
| August 07, 2026 | 12.37B |
| August 06, 2026 | 12.11B |
| August 05, 2026 | 12.27B |
| August 04, 2026 | 12.64B |
| August 03, 2026 | 12.14B |
| Date | Value |
|---|---|
| July 31, 2026 | 11.90B |
| July 30, 2026 | 12.27B |
| July 29, 2026 | 12.12B |
| July 28, 2026 | 12.06B |
| July 27, 2026 | 12.02B |
| July 24, 2026 | 12.03B |
| July 23, 2026 | 12.20B |
| July 22, 2026 | 12.47B |
| July 21, 2026 | 10.48B |
| July 20, 2026 | 10.07B |
| July 17, 2026 | 10.44B |
| July 16, 2026 | 10.03B |
| July 15, 2026 | 10.10B |
| July 14, 2026 | 10.11B |
| July 13, 2026 | 10.42B |
| July 10, 2026 | 10.74B |
| July 09, 2026 | 11.81B |
| July 08, 2026 | 12.05B |
| July 07, 2026 | 12.23B |
| July 06, 2026 | 12.17B |
| July 02, 2026 | 11.81B |
| July 01, 2026 | 11.31B |
| June 30, 2026 | 11.46B |
| June 29, 2026 | 11.32B |
| June 26, 2026 | 11.09B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.377B |
| Revolution Medicines, Inc. | 45.00B |
| Moderna, Inc. | 58.07B |
| Intellia Therapeutics, Inc. | 1.784B |
| Denali Therapeutics, Inc. | 3.559B |
Market Cap Related Metrics
| PS Ratio | 18.13 |
| PEG Ratio | -0.4964 |
| Price to Book Value | 26.18 |
| Price | 86.34 |
| Earnings Yield | -2.60% |
| PEGY Ratio | -0.4964 |